Ruth Mckernan

Insider Reports History

Entity
Individual
Location
C/O 235 East 42 Nd St., New York, NY
Signature
/s/ Mark Bodenrader, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ruth Mckernan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cerevel Therapeutics Holdings, Inc. Director Common Stock 0 $0 $41.18 Aug 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 0 Aug 1, 2024 Direct

Insider Reports Filed by Ruth Mckernan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CERE Cerevel Therapeutics Holdings, Inc. Aug 1, 2024 3 $0 4 Aug 5, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 7, 2023 2 $0 4 Jun 9, 2023 Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director